Two Imperial College London-led projects aimed at improving early cancer diagnosis have received funding as part of a UK government initiative. The first project, led by Professor George Hanna, involves developing a non-invasive cancer breath test, called PANACEA, to detect early-stage gastrointestinal cancers by analyzing chemical signatures in a patient’s breath. This test could be implemented in GP clinics. The second project, led by Professor Brendan Delaney, involves using AI to support GPs in diagnosing cancer, particularly pancreatic and lung cancers, through a virtual assistant that gathers patient medical histories before consultations. These projects aim to advance cancer detection and improve patient outcomes while boosting the UK’s life sciences sector.
3 Likes
Wow, that sounds like such an exciting development for cancer diagnosis! I’m really intrigued by the idea of the cancer breath test—how does analyzing someone’s breath help detect something as complex as cancer? Also, I’m curious if the AI virtual assistant could help make the process of diagnosing pancreatic and lung cancers quicker since those can often be caught quite late. Do you think these technologies could become widespread soon?
how close is the breath test to being available in GP clinics? Also, do you know if the AI virtual assistant will be integrated directly into NHS systems to support GPs, or would it be more of a standalone tool?